Home/Filings/4/0001628280-25-032855
4//SEC Filing

FOUSE JACQUALYN A 4

Accession 0001628280-25-032855

CIK 0001157601other

Filed

Jun 23, 8:00 PM ET

Accepted

Jun 24, 4:39 PM ET

Size

7.2 KB

Accession

0001628280-25-032855

Insider Transaction Report

Form 4
Period: 2025-06-20
Transactions
  • Award

    Common Stock

    2025-06-20+2031,097 total
  • Award

    Stock Option (Right to Buy)

    2025-06-20+366366 total
    Exercise: $285.73Exp: 2035-06-20Common Stock (366 underlying)
Footnotes (2)
  • [F1]Represents a grant of restricted stock units, which vest on the date of the Issuer's annual meeting of stockholders to be held in 2026, provided the Reporting Person continues in service with the Issuer on such date.
  • [F2]The option vests as to 100% of underlying shares on the date of the Issuer's annual meeting of stockholders to be held in 2026, provided that the Reporting Person continues to serve as a director of the Issuer until such date.

Issuer

MADRIGAL PHARMACEUTICALS, INC.

CIK 0001157601

Entity typeother

Related Parties

1
  • filerCIK 0001405288

Filing Metadata

Form type
4
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 4:39 PM ET
Size
7.2 KB